Clarify Pharma Past Earnings Performance
Past criteria checks 0/6
Key information
8.1%
Earnings growth rate
-21.3%
EPS growth rate
| Capital Markets Industry Growth | 16.3% |
| Revenue growth rate | n/a |
| Return on equity | -93.7% |
| Net Margin | n/a |
| Last Earnings Update | 31 May 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Clarify Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 May 23 | 0 | -1 | 1 | 0 |
| 28 Feb 23 | 0 | -1 | 1 | 0 |
| 30 Nov 22 | 0 | -1 | 1 | 0 |
| 31 Aug 22 | 0 | -1 | 1 | 0 |
| 31 May 22 | 0 | -1 | 1 | 0 |
| 28 Feb 22 | 0 | -1 | 1 | 0 |
Growing Profit Margin: PSYC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if PSYC's year-on-year earnings growth rate was positive over the past 5 years.